111, Inc. Stock

YI

US68247Q2012

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 00:00:00 13/06/2026 +04			5-day change	1st Jan Change
4.890 ^USD	+14.25%		+2.30%	+91.02%

06-12	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Marginally Lower for Week	MT
06-05	Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading	MT

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Companyâ€™s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Employees

1,063

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
12/06/26	4.890 $	+14.25%	63,632
11/06/26	4.280 $	-1.83%	47,994
10/06/26	4.360 $	-0.91%	25,702
09/06/26	4.400 $	-7.17%	10,041
08/06/26	4.740 $	-0.84%	15,731

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Market Cap	291M 43.02M 37.15M 34.24M 32.05M 60.06M 4.09B 60.99M 404M 158M 1.99B 161M 158M 6.89B	P/E Ratio 2024	-6.03x	P/E Ratio 2025	-2.35x
Enterprise Value	-59.26M -8.76M -7.56M -6.97M -6.52M -12.23M -832M -12.42M -82.29M -32.09M -405M -32.86M -32.16M -1.4B	EV / Sales 2024	0.01x	EV / Sales 2025	-0.02x
Free-Float	39.4%	Yield 2024 *	-	Yield 2025	-

06-12	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Marginally Lower for Week	MT
06-05	Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading	MT
06-04	111, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06-03	Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	MT
05-18	Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading	MT
05-12	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading	MT
04-30	111, Inc. Auditor Raises 'Going Concern' Doubt	CI
04-17	Asian Equities Traded in the US as American Depositary Receipts Surge in Friday Trading; Up 5% for Week	MT
04-14	Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading	MT
04-09	111, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
04-06	Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	MT
04-02	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT
03-13	Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT

06-04	111: Q1 Earnings Snapshot	AQ
06-04	111, Inc. Announces First Quarter 2026 Unaudited Financial Results	PR
04-10	111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results	AQ
04-09	111: Q4 Earnings Snapshot	AQ
12-18	111: Q3 Earnings Snapshot	AQ

1 day	+14.25%
1 week	+2.30%
Current month	-7.39%
1 month	-19.84%
3 months	-25.68%
6 months	+35.46%
Current year	+91.02%

1 week	4.05	5.23
1 month	4.05	6.36
Current year	2.48	11.17
1 year	2.48	11.17
3 years	2.48	33.6
5 years	2.48	101.8
10 years	2.48	458.8

111, Inc. Stock

Stocks

YI

US68247Q2012

Pharmaceuticals

Valuation: 111, Inc.

Chart: 111, Inc.

Latest news : 111, Inc.

Press Releases: 111, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: 111, Inc.

Latest insider transactions

Pharmaceuticals Wholesale

Financials

Company Profile

Quotes

Income Statement and Estimates

Quarterly revenue - Rate of surprise

Manager	Title	Age	Since
Jun Ling Liu CEO	Chief Executive Officer	61	01/05/2013
Yang Chen DFI	Director of Finance/CFO	56	04/11/2024

Director	Title	Age	Since
Gang Yu CHM	Chairman	66	01/05/2013
Jun Ling Liu CHM	Chairman	61	01/05/2013
Nee Chuan Teo BRD	Director/Board Member	55	01/09/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-11	Jian Sun	Sell	Director	-111,100	0.1175%
06-10	Jian Sun	Sell	Director	-115,440	0.1221%
05-27	Jun Luo	Sell	Director	-70,440	0.0745%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
111, INC.	+14.25%	+2.30%	-39.47%	-82.39%	43.02M
MCKESSON CORPORATION	-0.40%	+1.08%	+7.67%	+97.49%	94.25B
CARDINAL HEALTH, INC.	+1.22%	+8.82%	+38.68%	+154.32%	52.43B
SIGMA HEALTHCARE LIMITED	-1.86%	-9.59%	-18.77%	+214.29%	21.42B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+0.62%	+0.49%	-10.95%	-25.32%	8.13B
HUADONG MEDICINE CO., LTD	-0.07%	+2.43%	-34.66%	-28.05%	7.54B
SINOPHARM GROUP CO. LTD.	+1.19%	-1.22%	-11.46%	-36.80%	6.77B
H. LUNDBECK A/S	-2.80%	-2.46%	+11.48%	+21.79%	6.49B
GALENICA AG	+0.30%	+1.01%	-0.93%	+17.66%	5.32B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+1.27%	-3.62%	-11.95%	-14.53%	3.53B
Average	+1.37%	+1.07%	-7.04%	+31.85%	20.59B
Weighted average by Cap.	-0.06%	+3.45%	+9.45%	+103.84%

	2024	2025
Net sales	14.4B 2.13B 1.84B 1.69B 1.59B 2.97B 202B 3.02B 20B 7.8B 98.46B 7.99B 7.82B 341B	12.56B 1.86B 1.6B 1.48B 1.38B 2.59B 176B 2.63B 17.44B 6.8B 85.84B 6.96B 6.82B 297B
Net income	-64.74M -9.57M -8.26M -7.61M -7.13M -13.36M -909M -13.56M -89.91M -35.06M -443M -35.91M -35.14M -1.53B	-66.39M -9.81M -8.47M -7.81M -7.31M -13.7M -933M -13.91M -92.2M -35.95M -454M -36.82M -36.04M -1.57B
Net Debt	-225M -33.3M -28.76M -26.5M -24.81M -46.5M -3.17B -47.22M -313M -122M -1.54B -125M -122M -5.33B	-350M -51.77M -44.72M -41.21M -38.57M -72.29M -4.92B -73.4M -487M -190M -2.4B -194M -190M -8.29B